Nuclivision
PrivateLast Round
Seed
Apr 24, 2025
Total Funding Raised
$5.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Nuclivision is a healthtech company that develops AI-powered software, Nuclarity, designed to enhance PET imaging by reducing scan times and radiation exposure.
Sector
Enterprise Software
Verticals
Marketing, Digital Advertising, Content Creation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuclivision Comparables
Compare Nuclivision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Claritas HealthTech | 30% | |
Nuclivision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 24, 2025 |
Nuclivision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LUMO Labs | Seed |
| imec.istart | Pre Seed |
| HERAN Partners | Seed |
| Imec.iStart | Seed |
| Lumiares | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 21, 95% of headcount.
- Jul 13, 2026
Open roles increased to 14, 2.5x the trailing average.
Nuclivision Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nuclivision's valuation, stock price, and market status.